Prophylactic plasma concentration range of lithium in mEq does not include –
I remember that the therapeutic range for lithium is typically between 0.6 to 1.2 mEq/L for maintenance or prophylactic use. Sometimes, it might go up to 1.5 mEq/L, but anything above that increases the risk of toxicity. So if the question is asking which option doesn't include this range, the correct answer would be the one that's either too high or too low.
Wait, the user didn't provide the options, which is a problem. Without the options, it's hard to be precise. But maybe the correct answer given by the user is something like 1.5 mEq/L or 0.5 mEq/L. Let's assume the correct answer is an option that's outside the 0.6-1.2 range. For example, if one of the options is 1.5, then that's the one that's not included in the prophylactic range.
The core concept here is lithium's therapeutic index. Lithium has a narrow therapeutic window, so monitoring plasma levels is essential. The prophylactic range is lower than acute treatment levels. Acute mania might require higher levels, but for maintenance, it's lower. So if an option suggests a higher concentration, like 1.5 mEq/L, it's incorrect for prophylaxis.
Wrong options could include values like 0.4 mEq/L (too low to be effective) or 1.5 mEq/L (too high for maintenance). Each of these would be incorrect because they fall outside the prophylactic range. The clinical pearl here is to remember the range and that even slight increases can lead to toxicity. Students should note that prophylactic levels are lower than acute treatment levels to avoid toxicity.
**Core Concept**
Lithium is a first-line mood stabilizer for bipolar disorder. Its therapeutic plasma concentration for **prophylaxis** (maintenance therapy) is **0.6–1.2 mEq/L**, while acute treatment may require 1.5–2.0 mEq/L. Toxicity occurs above 1.5 mEq/L, necessitating strict monitoring.
**Why the Correct Answer is Right**
The prophylactic range (0.6–1.2 mEq/L) prevents relapse in bipolar disorder without causing nephrogenic diabetes insipidus or neurotoxicity. Lithium acts by inhibiting **inositol monophosphatase**, reducing cyclic AMP signaling in neurons. Higher concentrations risk **tremors, confusion, and renal tubular damage** due to its narrow therapeutic index.
**Why Each Wrong Option is Incorrect**
**Option A:** *(Example: 0.4 mEq/L)* – Below the therapeutic range, ineffective for prophylaxis.
**Option B:** *(Example: 1.0 mEq/L)* – Within the prophylactic range, correct for long-term use.
**Option D:** *(Example: 1.4 mEq/L)* – Approaches acute treatment levels;